The FTC said POM could state that its juice treated or prevented disease only if the claim was backed by at least one randomized, controlled clinical trial using human subjects.

The drug, Nuplazid, is expected to be priced at $13,500 per patient for a year, according to Leerink analyst Paul Matteis.

Children living in poverty have higher rates of chronic conditions like asthma and ADHD than kids who live in wealthier households — and that percentage is only growing.

The company said on Friday that it will cooperate with the Department of Justice to address any concerns.

The FDA is set to reevaluate whether a common anti-yeast infection drug may increase the risk of miscarriages in pregnant women.

Valeant Pharmaceuticals Chief Executive Michael Pearson plans to tell a U.S. Senate panel on Wednesday that he regrets his decision to acquire and jack up the price of two life-saving heart drugs, saying it was all a "mistake."

The administration said they pose an unreasonable and substantial risk to public health.

If signed into law, exemptions would be given for those who perform the procedure for reasons including protecting the mother or removing a miscarried fetus.

South Carolina Democrats pass a restrictive "Viagra bill" to mock repeated attempts by politicians to restrict abortion rights.

Portugal is possibly the only country in the world that changed its entire system to treat drug abuse as a health issue rather than a criminal justice problem, and it seems to be working. Here’s what the U.S. can learn from it.

Utah is taking a stand on pornography.

For some MS patients, cannabis is the only thing that relieves their pain, even if it's difficult to get legal access. Here's Charlie's story.